Individual and contextual factors influencing patient attrition from antiretroviral therapy care in an urban community of Lusaka, Zambia. by Musheke, Maurice et al.
Musheke, M; Bond, V; Merten, S (2012) Individual and contextual
factors influencing patient attrition from antiretroviral therapy care
in an urban community of Lusaka, Zambia. J Int AIDS Soc, 15 Suppl
1. pp. 1-9. ISSN 1758-2652 DOI: 10.7448/IAS.15.3.17366
Downloaded from: http://researchonline.lshtm.ac.uk/612276/
DOI: 10.7448/IAS.15.3.17366
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
Research article
Individual and contextual factors influencing patient attrition
from antiretroviral therapy care in an urban community
of Lusaka, Zambia
Maurice Musheke§,1,2,3, Virginia Bond1,4 and Sonja Merten2,3
§Corresponding author: Maurice Musheke, Zambia AIDS-related TB Research Project, University of Zambia, P.O. Box 50697, Lusaka, Zambia. Tel:260 211 254 710
(maurice.musheke@unibas.ch)
Abstract
Introduction: Despite the relatively effective roll-out of free life-prolonging antiretroviral therapy (ART) in public sector clinics in
Zambia since 2005, and the proven efficacy of ART, some people living with HIV (PLHIV) are abandoning the treatment. Drawing
on a wider ethnographic study in a predominantly low-income, high-density residential area of Lusaka, this paper reports the
reasons why PLHIV opted to discontinue their HIV treatment.
Methods: Opened-ended, in-depth interviews were held with PLHIV who had stopped ART (n25), ART clinic staff (n5),
religious leaders (n5), herbal medicine providers (n5) and lay home-based caregivers (n5). In addition, participant
observations were conducted in the study setting for 18 months. Interview data were analysed using open coding first, and then
interpreted using latent content analysis. The presentation of the results is guided by a social-ecological framework.
Findings: Patient attrition from ART care is influenced by an interplay of personal, social, health system and structural-level
factors. While improved corporeal health, side effects and need for normalcy diminished motivation to continue with treatment,
individuals also weighed the social and economic costs of continued uptake of treatment. Long waiting times for medical care
and placing ‘‘defaulters’’ on intensive adherence counselling in the context of insecure labour conditions and livelihood
constraints not only imposed opportunity costs which patients were not willing to forego, but also forced individuals to balance
physical health with social integrity, which sometimes forced them to opt for faith healing and traditional medicine.
Conclusions: Complex and dynamic interplay of personal, social, health system and structural-level factors coalesces to influence
patient attrition from ART care. Consequently, while patient-centred interventions are required, efforts should be made to
improve ART care by extending and establishing flexible ART clinic hours, improving patient-provider dialogue about treatment
experiences and being mindful of the way intensive adherence counselling is being enforced. In the context of insecure labour
conditions and fragile livelihoods, this would enable individuals to more easily balance time for treatment and their livelihoods.
As a corollary, the perceived efficacy of alternative treatment and faith healing needs to be challenged through sensitizations
targeting patients, religious leaders/faith healers and herbal medicine providers.
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Introduction
Even though the benefits of ART in reducing mortality among
people living with HIV (PLHIV) are well documented [16],
some PLHIV still drop out of treatment programmes [6,7]. An
analysis of 33 patient cohort studies from 13 Africa countries
revealed that on average, 60% of patients were retained in
ART care after 2 years of initiation [8]; another study has
reported retention rates of 75% at 12 months and 67% at 24
months [9]. Reasons for patient attrition from ART care have
included the use of traditional medicine [1012], costs,
side effects and stigma [13], and belief in faith healing
[12,14,15].
Zambia is one of the countries in sub-Saharan Africa
(SSA) worst hit by the HIV pandemic. Since 1984 when the
first case of HIV was detected, the country recorded a steady
increase in HIV prevalence, peaking at around 16% in the
1990s before levelling off and marginally declining to current
rates [16]. Recent estimates indicate that 14.3% of the
Zambian population (aged 15 to 49 years) is living with
HIV [17]. In 2005, the Zambian Government introduced free
ART services in public sector health facilities. This resulted
in a rapid increase in the number of PLHIV on treatment,
from 30,103 at the end of 2005, to an estimated 283,863
(adults and children) at the end of 2009 [16].
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Despite the provision of free treatment, some PLHIV still
drop out of ART care, running the risk of developing drug
resistance and negative health outcomes. Three case studies
in Lusaka, Zambia, identified the use of herbal remedies and
opting for faith healing as reasons for discontinuation of
ART [18] while two other studies [19,20] reported concerns
about side effects, food insecurity and mistrust of medication
as some of the factors influencing patient attrition from
ART care. While previous studies have provided insight into
the various reasons for non-uptake of ART, there is dearth
of evidence on how different factors interact to influence
health-seeking behaviour, including patient-health care pro-
vider interaction. In this study, we explored the reasons for
patient attrition from ART care in an urban community of
Lusaka, Zambia, in order to understand how PLHIV balance
their decisions based on the underlying framework of socio-
economic, cultural and health-system-related factors.
Methods
Theoretical framework: social-ecological framework
Over the years, various theories and models have been
developed to help understand health-seeking behaviour
[21,22]. We adapted the social-ecological framework by
Roura et al. [23] to explore the factors that influenced
patient attrition from ART care (Fig. 1). The theoretical
framework provides a comprehensive approach to under-
standing health-seeking behaviour. It frames human beha-
viour as a function of personal and environmental (social,
economic, political, health system) factors [21,2325].
The approach avoids exclusive focus on either individual or
environmental factors as separate analytical factors, but pays
attention to the dynamic interaction of both personal and non-
personal factors in understanding health-seeking behaviour
[23,25]. The premise of the framework is that individuals’
health-seeking behaviour is located in social, institutional and
physical environments, and consequently, behaviour shapes
and is shaped by, the social environment [23,26]. Health-
seeking behaviour is therefore construed not as something
that exclusively resides in the individual, but rather as a
reflection of wider interactive situational processes [22,23,27].
The social-ecological framework categorizes the factors
influencing health-seeking behaviour into individual, social,
health system and structural factors [23]. Individual-level
factors comprise personal characteristics such as perceived
disease severity, illness and wellness interpretations, and
knowledge and attitudes towards treatment, as well as
somatic response to medication [23,28].
Social factors include interpersonal relationships with
marital partners, family members and peers that in turn
affect individual behaviour and action [23]. Social factors also
include relationships with, and influence of, social institutions
like the church and traditional healthcare systems which
are deeply embedded in people’s socio-cultural systems.
Morality, norms and values reflect and shape social pro-
cesses. Social exclusion, discrimination and stigmatization are
located on this level, too. Similarly, the relationship between
health professionals and clients is structured by social order;
social distance and poor relationship between health workers
and patients affect access to treatment [28].
Structural factors are those external to the control of the
individual [29,30]. These include endemic poverty, livelihood
circumstances, health policies, laws and regulations, and
the financing of the healthcare system, which is linked to the
national economy [31,32].
Health system factors relate to the way health services
are organized and delivered [29]. These include availability
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Figure 1. Social-ecological framework: adapted from Roura et al. (2009) with permission from Mary Ann Liebert, Inc. Note: Left-right arrow
suggests a bi-directional relationship. For instance, failure to cope with side effects (individual level factor) may force PLHIV to opt for faith healing
(social factor). Similarly, lack of social network support (social factor) can affect attitude towards treatment leading to low self-efficacy.
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and accountability of services, attitude of providers, waiting
time and distance to health facilities [23,29].
Because of its comprehensive and multi-faceted approach,
the social-ecological framework avoids the theoretical divide
between ‘‘individualist’’ and ‘‘structuralist’’ models by treating
both paradigms as complementary and lying on the same con-
tinuum [23]. Individual, social, health system and structural-
level factors are viewed not as mutually exclusive, but
inextricably linked and in some cases mutually reinforcing.
For instance, health service interventions such as reduced
waiting times (health system factor) may improve patient
adherence behaviour through motivation to seek treatment
(individual factor); patients’ contact with the health system are
likely to be influenced by their attitude and beliefs about
treatment, and their lay interpretation of illness and wellness
[29]. Sometimes a combination of different level-factors may
influence non-uptake of treatment. For instance, pervasive
stigma (social factor) and longwaiting time at ARTclinic (health
system factor) may coalesce leading to lack of self-efficacy
(individual factor) resulting in patient attrition from ART care.
Research setting
The study was conducted in a predominantly low-income,
high-density urban residential setting of Lusaka, Zambia. The
setting comprises multilingual ethnic groups, with Bemba
and Nyanja the most widely spoken local languages. The
socio-economic status and housing conditions of the resi-
dents are mixed, but predominantly poor. The majority of the
residents are either in the informal sector of the economy
or in lowly paid jobs of the public and private sectors.
A lot more other people are not in any form of employment.
Health services in the area are mainly provided by a public
sector clinic which provides both in- and out-patient health
services. The clinic serves an estimated catchment population
of more than 150,000 people. The clinic has been providing
ART since 2006 and by mid-2010, the clinic had over 5,000
people on ART, and over 5,000 registered for pre-ART. In
addition to the requirement for every patient to have a
treatment supporter, called ‘‘buddy’’, the ART clinic runs a
treatment support group, and employs paid lay treatment
supporters that follow-up and trace treatment defaulters. A
community-based home-based care (HBC) programme also
provides physical, psychosocial and treatment support to
PLHIV.
There are also a myriad of traditional healers in the area;
some of them advertise their health services, including
treatment for sexually transmitted diseases (STIs) and
‘‘immune boosters’’ for HIV. Religion, particularly Christianity,
also plays a pivotal role in the lives of many people, providing
spiritual, material and social support. The major Christian
churches in the area are the United Church of Zambia (UCZ),
Roman Catholic Church, New Apostolic Church and the
Seventh-Day Adventist Church (SDA). There is also a growing
movement of evangelical charismatic Pentecostal churches,
some of which claim to provide faith healing for different
health problems, including HIV.
Research design and study participants
A descriptive qualitative study nested within a wider
ethnographic study was conducted. The study sample
comprised PLHIV (]18 years old and residents of the study
setting), classified as lost-to-follow-up (LTFU)/defaulters by
a local public sector clinic for missing their scheduled
pharmacy pick up for at least 6 months (180 days). The
revised Zambian ART treatment guidelines have reduced the
LTFU threshold to at least 60 days [33]. Our sample also
comprised ART staff of the local public sector clinic, home-
based care providers, herbal medicine providers and religious
leaders (Pastors) based in the study setting.
Participant recruitment strategy
All participants were recruited through a purposive sampling
strategy. This approach was used in order to identify
appropriate key informants (i.e. clinic staff involved in the
delivery of ART; religious leaders involved in faith healing and
herbal medicine providers). The sampling strategy also helped
identify PLHIV with unique and diverse experiences related to
discontinuation of treatment. PLHIV who had discontinued
ART were first contacted and recruited through ART staff.
From patient records, patient locator information was
extracted by ART staff to identify eligible participants. Other
research participants were identified and recruited through
their home-based care providers. The ART staff and home-
based caregivers explained the purpose of the research.
Table 1. Characteristics of PLHIV who stopped treatment
Characteristic Proportion of PLHIV
Age (years)
18 to 24 5
25 to 34 11
35 to 44 3
44 6
Sex
Man 8
Woman 17
Marital status
Single 4
Married 12
Divorced/separated 7
Widowed 2
Source of livelihood
Formal employment 4
Informal employment 15
Not working/dependant 6
Time on treatment
512 months 8
1 to 2 years 6
2 to 3 years 6
3 to 4 years 2
4 years 3
Duration not on treatment (up to time of interview)
6 to 12 months 10
1 to 2 years 8
2 to 3 years 5
3 to 4 years 2
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Data collection and analysis
Data were collected between September 2010 and March
2011. Open-ended in-depth interviews were held with PLHIV
who had stopped ART (n25), VCT/ART staff (n5),
religious leaders (n5), herbal medicine providers (n5)
and lay home-based caregivers (n5). The main research
question posed to PLHIV was: ‘‘What made you decide to
discontinue taking your HIV medication?’’ Key informants
were asked the question: ‘‘Why do PLHIV started on
treatment later discontinue their medication?’’ The majority
of the interviews were recorded using a digital audio
recorder. Where digital recording was not possible due to
respondent refusal or malfunctioning of the digital recorder,
the interviewer took detailed handwritten notes. Some of the
interviews were conducted in the local language, Nyanja, and
others in English. The interviews usually lasted between 30
and 45 minutes.
Structured observations were also conducted at the local
public sector ART clinic, at religious gatherings, including
church services. Social contact with residents, social institu-
tions and the local health system provided more in-depth
perspectives which helped situate PLHIV health-seeking
behaviour into their lives and experiences. The observations
also helped triangulate the data collected through in-depth
interviews. All interviews and observations were conducted
by the first author.
The interviews conducted in the local language were
translated, and all interviews were transcribed verbatim.
The interview transcripts were entered into, and managed
using Atlas ti version 6 software. We used latent content
analysis as described by Graneheim and Lundman [34]. The
transcripts were read several times to develop a sense of
the whole, and then conducted open coding of the data. The
codes were then compared for similarities and differences,
and then grouped into categories on a manifest level. Themes
were then generated by interpreting the categories for their
underlying meaning.
Observational notes were manually analysed to develop
broad themes that best captured and typologised the study
setting, and described the livelihood and treatment experi-
ences of PLHIV. In our study, the framework was not used for
thematic coding but served as a guide to present the results
in a structured way.
Protection of research participants
As a component of a bigger research project, ‘‘improving
equity of access to HIV care and treatment in Zambia’’, the
study was approved by the ethics committee of the state of
Basel (EKBB) and the University of Zambia Humanities and
Social Sciences Research Ethics Committee. Clearance was
also obtained from the Ministry of Health, at national and
district levels. Only PLHIV that had been contacted by ART
staff and home-based caregivers and agreed to be inter-
viewed were recruited for interviews. To ensure privacy and
confidentiality, the interviews took place in different settings,
mainly neutral locations depending on the preferences of the
respondents. Where appropriate, PLHIV were given lunch
and/or transport reimbursements (of up to US$10). All
research participants provided written informed consent.
Results
We first present individual-level, social and structural-level
factors emphasized by PLHIV in order to give an overview of
their main concerns. This is followed by findings that
specifically relate to patient-healthcare provider interaction,
in which individual, social, and structural factors are mirrored
as well.
Profile of PLHAs who had discontinued ART
A total of 25 PLHIV who had discontinued their treatment
were included in the analysis. The majority of the respon-
dents (n17) were women, and nearly half (n11) were
aged between 25 and 34 years. The oldest respondent was a
widow aged 48 years. More than half (n15) of the PLHIV
were in informal employment. In terms of treatment history,
8 of the 25 PLHIV had been on treatment for up to a year;
and less than half (n10) abandoned medication within a
year of starting treatment (Table 1).
Reasons for patient attrition from ART care
Individual-level factors
Side effects and treatment beliefs: Treatment-related
side effects were a recurrent theme for discontinuing
treatment. The frequently mentioned side effects were
severe stomach pain and diarrhoea, severe leg pain and
headache, body rash, fatigue and vomiting. While PLHIV
acknowledged that side effects were inevitable, they felt that
the side effects were inimical to their health and comfort and
interfered with their engagement in livelihood activities. An
unemployed 33-year-old woman narrated how side effects
sapped her energies and made her incapable of engaging in
livelihood activities:
The time I was on treatment, I used to feel weak all
the time. I used to feel dizzy. I used to fail to carry
even a 10 litre container of water. I could not do any
piece works to make money. Although I still cough,
its much, much better now than when I was on
treatment.
Some PLHIV expressed concerns about the dangers of
treatment to their lives and long-term health. One respon-
dent narrated: ‘‘Those drugs almost killed me. I almost went
mad. Today, if I was still taking those drugs, I would either be
mad or I would have died by now’’ (28-year-old woman).
Although not explicitly expressed by others, one PLHIV felt
that while the drugs generally improved health, they also
inflicted debilitating effects in the long term:
The problem with ARVs is that you become fat first
before you die, that you look healthy outwardly, but
inside your body, you are rotten, being eaten up by
the drugs. (48-year-old woman)
Treatment fatigue and low self-efficacy: While side
effects were a reason for abandoning treatment, improving
wellbeing decreased motivation to continue on treatment
too. Often triggered by physical improvements of corporeal
health, some PLHIV saw no need to continue with treatment.
One participant said: ‘‘To tell you the truth, I have consumed
Musheke M et al. Journal of the International AIDS Society 2012, 15(Suppl 1):17366
http://www.jiasociety.org/index.php/jias/article/view/17366 | http://dx.doi.org/10.7448/IAS.15.3.17366
4
those drugs, I am now tired . . ..Now that I feel better,
I decided to stop’’ (48-year-old woman).
Change of identity: A few PLHIV emphasized their desire
to feel ‘‘normal’’: continued uptake of treatment often
reminded them of being ‘‘sick’’, having an incurable and
fatal condition, and dependent on medication. Therefore to
contruct a positive and ‘‘healthy’’ image of themselves,
they opted to discontinue their medication. As one PLHIV
explained:
Taking ARVs always reminds you of HIV. Sometimes
you just want to forget about it, to be like others
who are not infected. So when you feel ok, you want
to stop taking the drugs so that you also feel that
you are also a normal person. (34-year-old man)
Social-level factors
Fear of losing social and emotional support due to
anticipated stigma: Some PLHIV were fearful of involuntary
disclosure of their status, either to their marital partners
or other social network members and facing the prospects
of social exclusion. Especially women, social support was
crucial because of their surbordinate socio-economic status.
Some women were full-time housewives and/or small traders
operating small makeshift shops locally called tutembas.
Consequently, to avoid involuntary disclosure of their HIV
status, they opted to stop treatment in order to preserve
social support systems. One woman narrated her dilemma:
I feared that my husband would know, and if he
knew, he was going to divorce me. Where can I go if
I got divorced? Who will look after my children?
I just said to myself that it is better I stop medication
so that I can protect my marriage, and so that my
children can have a future. (32-year-old woman
living with HIV)
Social network influence and experiences: In some
cases, PLHIV stopped treatment altogether or opted for faith
healing and herbal remedies after being influenced by, and
drawing on the health experiences of, other PLHIV who had
stopped treatment. This was confirmed by ART staff, home-
based caregivers and a few PLHIV. As an ART staff explained:
Some people boast [among their friends] that
‘‘here I am, I stopped medication but I am just
fine’’. So when other people see that, they also think
that you can stop treatment and nothing would
happen to you.
Faith in God: Personal relationship with, and trust in, a
surpernatural being (God) also led to patient attrition from
ART care. The majority of the respondents interviewed
professed being Christians and some narrated how being
‘‘born-again’’ and their ‘‘personal relationship’’ with God
dissuaded them from continuing with treatment. A 47-year-
old widow who underwent some healing sessions explained:
I give praise to God that He healed me. I never
thought that I would be healed because I was HIV
positive. I used to take my medication every day, in
the mornings and in the evenings. And at the clinic,
they told me that if you stop taking your medication,
you will die. But me, I stopped treatment and I have
not died, I am still alive. God is great. Glory be to
God.
Observations revealed that some local Pentecostal churches
hosted healing sessions for people suffering from different
ailments, including HIV. One Pentecostal church conducted
healing prayer sessions every Saturday; on the wall of the
local church read the banner: ‘‘Come for counselling,
deliverance and healing from all sickness and disease’’.
Another Pentecostal church conducted ‘‘deliverance and
healing’’ sessions every Wednesday and Thursday afternoon.
During one of the church services, a middle-aged woman
testified about how she was found HIV positive at a local
public sector clinic and put on medication but opted to put
her faith in God. She testified in church:
I embarked on prayer and fasting . . .. I told the devil
that you are a liar. I asked God, can you show your
power, and thank God, I am cured. Our living God is
a God of wonders.
The practice of faith healing was confirmed by evangelical
Pastors, ART staff and home-based care providers. People
moved across Christian denominations in search of healing.
An ART staff recounted an incident where ARVs were dumped
at the ART clinic during the same week that a visiting Pastor
conducted a series of ‘‘deliverance and healing’’ sermons in
the area.
One of the local Pastors interviewed explained:
We pray for them and never lose hope even at the
point of death. We still stand by the word of God,
that God is able to cure or heal you. If God does not
cure you, it is because of His personal reasons.
Another Pastor proclaimed:
The Bible teaches us that the things which are
impossible with men are possible with God.
Opting for alternative treatment: In the study setting,
alternative forms of treatment co-existed with ART care.
PLHIV accessed herbal remedies either from traditional
healers or from herbal medicine traders. Some of these
remedies were being used either as purported cures or as
‘‘immune boosters’’. These remedies included crocodile fats,
moringa oleifera and aloe vera gel (also locally available
in plant form called tembusha). While some PLHIV initially
used herbal medicines concurrently with ART, overtime,
they reported exclusively opting for herbal remedies. For
some, opting for alternative treatment was triggered by
ART-induced side effects, dissatisfaction with ART care
and inability to stick to the stringent ART regimen. For other
PLHIV, the quest to get cured attracted them to use herbal
remedies. One PLHIV explained:
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I never had any problem with the health
workers. But I just decided on my own when
I heard that crocodile fats cure, so I decided to start
taking crocodile fats in the hope of being healed.
(46-year-old man)
A herbal medicine trader supplying herbal medication to
PLHIV claimed that her herbal remedies were as effective
as ART in boosting the immune system:
I have different types of herbs which improves the
health of people who have HIV. Some of the
herbs boost the immune system. I also have other
herbs that cleanse the body of toxins. Some of my
customers were not recovering when they were
taking ARVs,but when they started taking my herbs,
their health improved.
Structural-level factors
Insecure labour conditions: For some PLHIV, the fear of
losing their jobs on account of their HIV status, anticipating
stigma, hindered them from accessing treatment. Most
people, even when employed, did not have proper contracts
which would protect them in case of illness as foreseen by
the law. People with job insecurity who also reported earning
meagre income did not want to lose their livelihoods on
account of disclosure of their HIV status. The lack of
both formal and strong informal social safety nets reinforced
the need to preserve sources of socio-economic support.
One woman said:
I lost my marriage when I told my husband my
status . . ..So I did not tell my boss that I was HIV
positive, so I feared that if I told her, she was going
to fire me. So I decided to keep quiet so that I keep
my job . . ..Instead, I decided to stop going to the
clinic so that she does not know my status. (30-year-
old divorced woman)
Poor labour conditions that did not respect employees’
right of access to healthcare also made it difficult for PLHIV
to reconcile time for treatment and their livelihoods. The
majority of our respondents were engaged in informal,
low-income livelihoods (i.e. bus drivers, house maids, con-
struction workers, petty traders) and getting time off-
work presented enormous opportunity costs. Some PLHIV
experienced worse dilemmas. A Zambian truck driver work-
ing for a South African-based transport company narrated
his harrowing experience:
My drugs got finished when I was in South Africa.
The problem was that when I told my boss that
I want to go to Zambia for treatment, he told me
that ‘‘if you decide to go, you should never come
back for work’’. So you know how hard jobs are
to find. So I just decided to hang around so that I do
not lose my job. (32-year-old truck driver)
Sometimes PLHIV ‘‘cooked-up’’ stories that would generate
compassion from employers such as a child, wife or husband
being sick at home or the need to attend a funeral of a close
relative. Even where permission was obtained, PLHIV had to
tread a thin line between accessing treatment and securing
their jobs. The frequency of getting permission had to be
minimal to avoid being misconstrued by employers as not
being committed to work. One 30-year-old PLHIV who lost his
job twice, first as a plumber and then as a minibus conductor,
after frequently getting permission from work to seek
treatment narrated his ordeal:
Your health is your health, and what they
[employers] care about is their business, doing their
work. Sometimes if you ask for permission fre-
quently, they think that you are just giving excuses.
So, they fire you and replace you with someone else.
That is how I lost my jobs.
Health system-level factors
Competing priorities and dissatisfaction with ART
care. When livelihood problems and low perceived quality
of care coalesced, incentives to stay on treatment
diminished. For some PLHIV, long waiting time and frequent
trips to the clinic presented enormous opportunity costs
which they were not willing to forego. This was especially
the case for those who reported living ‘‘hand-to-mouth’’
livelihoods or were in insecure employment and therefore
frequent trips to the clinic ‘‘forced’’ them to choose
between treatment and their livelihoods. Relatedly, the
long clinic appointments often lasting almost a whole day,
non-availability of some drugs and laboratory test results,
and perceived rudeness of some clinic staff frustrated and
dissuaded other PLHIV from seeking ART care. A woman in an
HIV concordant marriage narrated their disillusionment with
ART care:
Sometimes, you go there, they collect your blood,
but the next time you go to the clinic, they tell you
that your results got lost and you should give fresh
blood and come again after two weeks. That
frustrates a lot of people.. . . One time, my hus-
band’s results and my results got lost twice. (33-
year-old woman)
Dissatisfaction with the way clinic staff responded to
patients’ concerns included the problem of side effects,
too. Several PLHIV reported not going back to the clinic to
report side effects; others indicated that whenever they did,
ART staff often dismissively told them that ‘‘you will be fine
once your body gets used to the medication’’ (32-year-old
man). The unresolved concerns about side effects often
triggered PLHIV to opt for faith healing and herbal remedies.
Paradoxical impact of intensive adherence counselling.
In order to reduce non-adherence, clinic staff included the
so-called ‘‘defaulters’’ in special counselling programmes. The
compulsory participation in intensive adherence counselling
offered by the ART clinic involved reverting ‘‘defaulters’’ to
weekly doses of treatment in which they were asked to
report to the clinic weekly for adherence counselling for at
least a month. This exasperated the balancing act between
treatment and livelihoods. Several PLHIV described this
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approach as insensitive and a threat to their livelihoods.
Looking livid, one 30-year-old woman complained:
Do we only live to go to the clinic or we also have
other things to do in life? If I keep on spending time
at the clinic, then, how I am going to look after
myself and my family? What will we be eating with
my family? What time would I have to go and do my
work to earn a living? This really annoyed me and I
got fed up with the clinic and decided to stop my
medication.
Another PLHIV, a second-hand clothes trader, opted to
stop treatment after being put on intensive adherence
counselling. She reportedly attended her mother’s funeral
outside Lusaka and missed her clinical appointment by four
days because she stayed longer for the funeral than
anticipated. When she returned to the clinic, she was
classified as a ‘‘defaulter’’ and immediately put on intensive
adherence counselling despite not intentionally missing her
clinical appointment. She complained:
I went with my medication but because I stayed
there [at the funeral] for a week, my medication got
finished. But then they [ART staff] just said that we
will give you drugs for one week and put you on
intensive adherence counselling. The counsellor just
said you patients are a problem, you just want to
come to the clinic whenever you feel like. This put
me off. It was like I was being punished for attending
my mother’s funeral. (21-year-old woman)
Discussion
The results illustrate how individual-level, social and struc-
tural-level factors influencing why patients discontinued ART
care in an urban community of Lusaka are equally character-
izing the patient-provider interaction. Every person who
stopped ART did this knowing that this was against the
recommendations of the health system.
When looking at individual-level reasons given by PLHIV,
treatment was often interrupted when side effects became
too severe or were perceived as compromising quality of
life, a finding reported in many other studies, too [3538]. The
health system’s response that side effects would disappear
after some time was not convincing to many PLHIV. Our
findings suggest that the conception of being healthy is
subjectively experiential rather than shaped by laboratory test
results that cannot be felt [39,40]. Patient’s perceptions of the
impact of treatment on physical, physiological and psycholo-
gical wellbeing influenced their decisions. For instance, lack of
motivation to continue with treatment was influenced by
perceived improvement of corporeal health. In this case, good
health and wellbeing are not only about improved CD4 cell
count and lower viral load as measured in bio-medical
discourse, but also in terms of comfort and unfettered ability
to participate in day-to-day life activities [40]. Indirectly, this
shows that the expert opinions of the ART providers are not
trusted enough to legitimate a continuation of treatment.
Individual health-seeking behaviour is also strongly influ-
enced by, and responds to, factors in the immediate social
environment [23]. Social exclusion and discrimination is
anticipated in case of disclosure of one’s positive status.
PLHIV fear the breakdown of their marriages, families, and
loss of employment. In the absence of institutional social
safety net, individuals rely exclusively on social network
support to cope with unforeseen events. However, when
social support is threatened by involuntary disclosure of HIV
status, individuals abandon treatment as a protective
mechanism.
Public identity transformation was avoided by all means
especially if PLHIV were dependent on their social support
networks. A strong urge to be ‘‘normal’’ was characterized by
a variety of strategies of PLHIV. One example are the religious
coping strategies of PLHIV, which cannot be discussed
separately from the stigma associated with the condition of
being HIV positive.
Despite the availability of antiretrovirals and the good
health of many PLHIV, the moral dimension of HIV has not
diminished, at least in this community. Coupled with
livelihood insecurity, disclosure of a positive HIV status
breeds tremendous social insecurity and loss of material
and emotional support by spouses, families and friends.
PLHIV coping strategies, such as re-establishing normalcy
through being healed, unfortunately often implies abandon-
ment of antiretroviral therapy.
Structural factors influence patient attrition as well. Our
findings further suggest that livelihood constraints character-
ized by low-income, labour condition constraints and absence
of strong formal and informal socio-economic safety nets
affected patient continuation with treatment. While previous
studies have found no correlation between poverty and
adherence to treatment [41,42], other findings have reported
the negative impact of livelihood constraints on treatment
adherence [43,44]. Our findings suggest that in settings with
endemic poverty levels and weak social safety net, indivi-
duals are inclined to avoid actions that would expose them to
further socio-economic vulnerability.
These findings need to be contextualized. Zambia ranks
poorly (164 out of 187 countries) on the human development
index (HDI) [45]; 68% of its population falls below the
national poverty line [46]; and 90% of the labour force is in
informal sector employment [47]. Consequently, even where
PLHIV are motivated to continue accessing treatment, health-
seeking behaviour is undermined by coalesced effect of non-
individual level factors such as fragile livelihoods, health
system factors like long waiting times for medical care, which
in turn compels PLHIV to prioritize their livelihoods over their
health. Thus, to still maintain ‘‘good’’ health, some PLHIV opt
for alternative forms of healthcare, like herbal remedies
because they are easily accessible and do not impose
inordinate opportunity costs.
Since the beginning of ART care, the health sector has tried
many support strategies to improve adherence. Nonetheless,
there are shortcomings of ART delivery, which are partly due
to resource constraints. Similar to findings from previous
studies [48,49] long waiting times at health facilities affected
patient access to treatment. In contrast, however, neither the
costs of treatment nor distance to the medical facilities were
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influencing patient attrition from ART care because ART
services were free and within reach in this urban community.
Unexpectedly, however, specific interventions aimed at
improving adherence to ART seemed counter-productive. This
was the case for putting ‘‘defaulters’’ on intensive adherence
counselling. What was striking in our study, which previous
studies in Zambia have not reported [19,20], was the negative
impact of intensive adherence counselling on patient reten-
tion in ART care. For patients, this was interpreted as being
‘‘punished’’ for circumstances beyond their control. Conse-
quently, while aimed at achieving positive ‘‘quantitative
aspects of HIV management and monitoring’’ [40], intensive
adherence counselling was also achieving the opposite. Our
findings corroborate the findings of Tugenberg et al. [50] who
found that heavy insistence on adherence by clinicians forced
some PLHIV to abandon medical visits to avoid confrontations
with their doctors for non-adherence. Thus, perceived
unresponsiveness of the health system pushes patients to
seek alternative forms of healthcare, such as faith healing
[15,51,52] and traditional medicine [12,18,53].
Possible limitations of the study
This study was conducted in an high-density, generally poor
urban setting, with a small purposively chosen sample of
PLHIV. The findings may not be fully generalizable to other
settings. Each setting may have unique characteristics that
may influence health-seeking behaviour. However, our study
has generated new insights about patient-provider interac-
tions, the role of faith healing and traditional medicine,
which may be generalizable beyond our setting and which
contributes to the body of evidence on factors influencing
patient retention in ART care.
Conclusions
Patient attrition from ART care is not exclusively an individual
choice, but affected by a complex and dynamic interplay of
personal, social, health system and structural-level factors.
Even for the most motivated patient, being on life-long
treatment is not easy. Patients have to balance the exigencies
of treatment with the effects of accessing treatment on their
social, physical, mental and economic well-being. Therefore,
while patient-centred interventions are critical to promote
adherence, there is need to be mindful of, and address the
influence of, non-personal-level factors which interact to
influence health-seeking behaviour. This is crucial to achieve
needs-based, demand-driven and beneficiary responsive ART
care and ultimately retain patients in treatment programmes.
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